Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A DECKER

Showing results (711-720 of 718) with videos related to

Pageof 72
Sort By:
You have reached the last page of results.This site can display upto 718 results.
Nature Genetics|August 28, 2012
A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutationRobert B Jenkins, Yuanyuan Xiao, Hugues Sicotte, et al.
The New England Journal of Medicine|June 11, 2015
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in TumorsJeanette E Eckel-Passow, Daniel H Lachance, Annette M Molinaro, et al.
JAMA Oncology|February 7, 2020
Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed GlioblastomaAnnette M Molinaro, Shawn Hervey-Jumper, Ramin A Morshed, et al.
Plos One|January 10, 2024
Researching COVID to enhance recovery (RECOVER) tissue pathology study protocol: Rationale, objectives, and designAndrea B Troxel, Marie-Abele C Bind, Thomas J Flotte, et al.
Science (New York, N.Y.)|October 6, 2022
A noncoding single-nucleotide polymorphism at 8q24 drives <i>IDH1</i>-mutant glioma formationConnor Yanchus, Kristen L Drucker, Thomas M Kollmeyer, et al.
Physical Review Letters|December 13, 2024
New Upper Limit on the Axion-Photon Coupling with an Extended CAST Run with a Xe-Based Micromegas DetectorK Altenmüller, V Anastassopoulos, S Arguedas-Cuendis, et al.
Nature Genetics|March 28, 2017
Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumorsBeatrice S Melin, Jill S Barnholtz-Sloan, Margaret R Wrensch, et al.
Nature Genetics|September 28, 2011
A germline variant in the TP53 polyadenylation signal confers cancer susceptibilitySimon N Stacey, Patrick Sulem, Aslaug Jonasdottir, et al.
Pageof 72

Showing results (711-720 of 718) with videos related to

Sort By:
Pageof 72
You have reached the last page of results.This site can display upto 718 results.
Nature Genetics|August 28, 2012
A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutationRobert B Jenkins, Yuanyuan Xiao, Hugues Sicotte, et al.
The New England Journal of Medicine|June 11, 2015
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in TumorsJeanette E Eckel-Passow, Daniel H Lachance, Annette M Molinaro, et al.
JAMA Oncology|February 7, 2020
Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed GlioblastomaAnnette M Molinaro, Shawn Hervey-Jumper, Ramin A Morshed, et al.
Plos One|January 10, 2024
Researching COVID to enhance recovery (RECOVER) tissue pathology study protocol: Rationale, objectives, and designAndrea B Troxel, Marie-Abele C Bind, Thomas J Flotte, et al.
Science (New York, N.Y.)|October 6, 2022
A noncoding single-nucleotide polymorphism at 8q24 drives <i>IDH1</i>-mutant glioma formationConnor Yanchus, Kristen L Drucker, Thomas M Kollmeyer, et al.
Physical Review Letters|December 13, 2024
New Upper Limit on the Axion-Photon Coupling with an Extended CAST Run with a Xe-Based Micromegas DetectorK Altenmüller, V Anastassopoulos, S Arguedas-Cuendis, et al.
Nature Genetics|March 28, 2017
Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumorsBeatrice S Melin, Jill S Barnholtz-Sloan, Margaret R Wrensch, et al.
Nature Genetics|September 28, 2011
A germline variant in the TP53 polyadenylation signal confers cancer susceptibilitySimon N Stacey, Patrick Sulem, Aslaug Jonasdottir, et al.
Pageof 72